Search Results

You are looking at 81 - 90 of 508 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Sumesh Kachroo, Changxia Shao, Kaushal Desai, Jinghua He, Fan Jin, and Shuvayu Sen

the deidentified Flatiron Health-Foundation Medicine Clinico-Genomic Database linking clinical electronic health records and comprehensive genomic profiling (CGP) data from January 2011-September 2018. Patients ≥18 years with confirmed SCLC pathology

Full access

Benjamin O. Anderson

limited-resource countries: early detection and access to care . Breast J 2006 ; 12 [ Suppl 1 ]: S16 – 26 . 11. Shyyan R Masood S Badwe RA . Breast cancer in limited-resource countries: diagnosis and pathology . Breast J 2006 ; 12 [ Suppl

Full access

Margaret Tempero

. And it accomplishes a lot with a lean budget. The Association for Molecular Pathology has issued a statement broadly opposing the FDA in this new effort. 3 They have legitimate concerns, but I disagree with their opposition. I don’t think we should

Full access

Lauren E. Kernochan and Rochelle L. Garcia

Edited by Kerrin G. Robinson

. 11 Robboy SJ Mutter GL Prat J ., eds. Robboy’s Pathology of the Female Reproductive Tract . 2nd ed . China : Churchill Livingstone Elsevier ; 2009 . 12 Teo SY Babagbemi KT Peters HE Mortele KJ . Primary malignant mixed mullerian

Full access

Richard S. Matulewicz, Brendan T. Frainey, Daniel T. Oberlin, and Joshua J. Meeks

clinical T1HG bladder cancer. All staging was defined by the AJCC 7th Edition. Clinical stage in the NCDB is based on examination under anesthesia and TURBT, whereas final pathologic stage is based on RC pathology. Urothelial histology was determined via

Full access

Pancreatic Adenocarcinoma, Version 2.2012

Featured Updates to the NCCN Guidelines

Margaret A. Tempero, J. Pablo Arnoletti, Stephen W. Behrman, Edgar Ben-Josef, Al B. Benson III, Ephraim S. Casper, Steven J. Cohen, Brian Czito, Joshua D. I. Ellenhorn, William G. Hawkins, Joseph Herman, John P. Hoffman, Andrew Ko, Srinadh Komanduri, Albert Koong, Wen Wee Ma, Mokenge P. Malafa, Nipun B. Merchant, Sean J. Mulvihill, Peter Muscarella II, Eric K. Nakakura, Jorge Obando, Martha B. Pitman, Aaron R. Sasson, Anitra Tally, Sarah P. Thayer, Samuel Whiting, Robert A. Wolff, Brian M. Wolpin, Deborah A. Freedman-Cass, and Dorothy A. Shead

recommendations. Although the subcommittee members agreed that the data and information in the pathology report should be standardized and mandated, many felt strongly that how the information is obtained should be left to the discretion of individual surgeons and

Full access

Shajan Peter

recommendations. One CDT is the EHR-based Colonoscopy Pathology Reporting and Clinical Decision Support System (CoRS) described by Magrath et al elsewhere in this issue. They analyzed the usefulness of this integrated digital system to determine adherence to the

Full access

features of Mayo Clinic Cancer Center's pathology department and the frozen section laboratory—every sample is frozen, and the well-designed work flow that allows for very high-quality pathology work to be completed in a controlled time frame. Dr

Full access

Charles L. Loprinzi and Peter M. Ravdin

2000 ; 14 : 33 – 49 . 10 Goldhirsch A Glick JH Gelber RD . Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer . J Clin Oncol 2001 ; 19 : 3817 – 3827 . 11 Schnitt SJ Guidi AJ . Pathology

Full access

facilitated by 2 faculty members from NCCN Member Institutions to provide multidisciplinary perspectives, including pathology, medical oncology, surgical oncology, and radiation oncology. A different topic will be presented each month for 12 months, beginning